<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Antibiotic Susceptibility Patterns of Uropathogens Isolated from Female Patients with Urinary Tract Infection in Duhok Province, Iraq
2
antibiotic susceptibility profile of bacteria causing aerobic vaginitis in women in iraq
3
Antibiotic Susceptibility Profile of Group B Streptococcus (Streptococcus agalactiae) at the Maternity Hospital, Kuwait
4
Antibiotic susceptibility profile of Pseudomonas species isolated from clinical specimens to access, watch and reserve drugs across various hospital settings at a tertiary care hospital of central India
5
Antibiotic Susceptibility Profile, ESBL Production and blaCTX-M1, blaSHV and blaTEM Types Among Escherichia coli Blood Isolates
6
Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains
7
Antibiotic susceptibility testing of Bifidobacterium thermophilum and Bifidobacterium pseudolongum strains: Broth microdilution vs. agar disc diffusion assay
8
Antibiotic swings and roundabouts
9
Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia
10
Antibiotic Therapy and Complete Oral Feeding Tolerance in Premature Neonates
11
Antibiotic therapy and peritonitis
12
Antibiotic therapy for the treatment of preterm labor: A review of the evidence
13
Antibiotic Therapy for Very Low Birth Weigh Newborns in NICU
14
Antibiotic Therapy in Asthma as One of First Step Treatment, a Phase 3 Randomized Clinical Trial
15
Antibiotic therapy in preterm premature rupture of membranes: Are seven days necessary? A preliminary, randomized clinical trial
16
Antibiotic therapy—managing odontogenic infections
17
Antibiotic treatment enhances C2 toxin production by Alexandrium tamarense in batch cultures
18
Antibiotic treatment for acute bronchitis
19
Antibiotic treatment for acute maxillary sinusitis
20
Antibiotic treatment for giant-cell arteritis?
21
Antibiotic treatment in acute bacterial sinusitis
22
Antibiotic treatment in acute bacterial sinusitis
23
Antibiotic treatment in acute bacterial sinusitis
24
Antibiotic treatment in patients with altered pathophysiolocical pathways
25
Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: A metaanalysis, ,
26
Antibiotic Treatment of Anaerobic Infections: Uncharted Land in Iran
27
Antibiotic Treatment of Animals – A Different Approach to Rational Dosing
28
Antibiotic treatment of bacterial vaginosis in pregnancy: A meta-analysis
29
Antibiotic uceptibility of Bacterial Iolate from Bacterial Keratiti Cae in a Univerity Hopital in Taiwan Original Reearch Article
30
Antibiotic uceptibility of preoperative normal conjunctival bacteria
31
Antibiotic Usage Measured by Absence of Microbial Growth on Gram Stain and/or Culture
32
Antibiotic usage pattern in selected poultry farms in Ogun state
33
Antibiotic use and cost indicators at a rural hospital: A pilot project
34
Antibiotic use and knowledge in the community in Kalamoon, Syrian Arab Republic: a cross-sectional study
35
Antibiotic use and occlusive stroke: weighing a negative result
36
Antibiotic use and resistance—proving the obvious
37
Antibiotic use and risk of ischemic stroke in the elderly
38
Antibiotic Use and Symptoms of Asthma, Allergic Rhinitis and Eczema in Children.
39
Antibiotic Use and Upper Respiratory Infections: A Survey of Knowledge, Attitudes, and Experience in Wisconsin and Minnesota
40
Antibiotic use for emergency department patients with acute diarrhea: Prescribing practices, patient expectations, and patient satisfaction
41
Antibiotic Use for Emergency Department Patients With Upper Respiratory Infections: Prescribing Practices, Patient Expectations, and Patient Satisfaction
42
Antibiotic use in a periurban community in Mexico: A household and drugstore survey
43
Antibiotic use in early childhood and the development of asthma
44
Antibiotic use in pregnancy and drug-resistant infant sepsis
45
Antibiotic Use in Some Nigerian Communities: Knowledge and Attitudes of Consumers
46
Antibiotic Use Pattern of Surgical Site Infection Prophylaxis in Surgical Wards of a Teaching Hospital in Shiraz, Iran
47
Antibiotic use, Abuse and their Public Health Implication: The Contributory role of management Flaws in the Poultry Industry in two Agro-Ecological Zones in Ghana
48
Antibiotic Utilization in Iran 2000–2016: Pattern Analysis and Benchmarking with Organization for Economic Co-operation and Development Countries
49
Antibiotic Utilization Patterns in Patients with Ventilator-Associated Pneumonia: A Canadian Context
50
Antibiotic-associated diarrhoea
51
Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter–related infections: a prospective, randomized study
52
Antibiotic-conjugated polyacrylate nanoparticles: New opportunities for development of anti-MRSA agents
53
Antibiotic-containing semen extender reduces the risk of transmission of CEM
54
Antibiotic-containing semen extender reduces the risk of transmission of CEM
55
Antibiotic-eluting bioresorbable composite fibers for wound healing applications: Microstructure, drug delivery and mechanical properties
56
Antibiotic-free composite bone cements with antibacterial and bioactive properties. A preliminary study
57
Antibiotic-laden Arthroplasty with a Novel Design of Cement Mould and Metallic Endoskeleton for Treatment of Hip Infection, an Inexpensive Alternative: A Preliminary Report of Two Cases
58
Antibiotic-loaded acrylic bone cements: An in vitro study on the release mechanism and its efficacy
59
Antibiotic-loaded bone cement reduces deep infection rates for primary reverse total shoulder arthroplasty: a retrospective, cohort study of 501 shoulders
60
Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis
61
Antibiotic-resistant Bacteria in Hospitalized Patients with Bloodstream infections: Analysis of Some Associated Factors
62
Antibiotic-Resistant Escherichia coli Isolated from Duck Cloacal and Tap Water Samples at Live Bird Markets in Bangladesh
63
Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: Retrospective and prospective surveillance
64
Antibiotic-Resistant Pattern and Multiple Antibiotic Index of Multidrug-Resistant Staphylococcus aureus from Wound Infection Patients in a Tertiary Institution in South Eastern Nigeria
65
Antibiotic-resistant Salmonella Species in Pork on Display for Sale in Umuahia, Abia State, Nigeria
66
Antibiotic-resistant Salmonella spp. from human and non-human sources in Oman
67
Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction
68
Antibiotics and heavy metals resistance patterns of Enterococcus faecalis and faecium bacteria isolated from the human and the livestock sources
69
Antibiotics and oral contraceptives
70
ANTIBIOTICS AND THE MECHANISMS OF RESISTANCE TO ANTIBIOTICS
71
Antibiotics Are Not Beneficial in the Management of Category III Prostatitis: A Meta-Analysis
72
Antibiotics as Microbial Secondary Metabolites: Production and Application
73
Antibiotics for acute infective conjunctivitis in children
74
Antibiotics for acute infective conjunctivitis in children
75
Antibiotics for acute infective conjunctivitis in children
76
Antibiotics for acute infective conjunctivitis in children – Authorsʹ reply
77
Antibiotics for acute otitis media: a meta-analysis with individual patient data
78
Antibiotics for acute rhinosinusitis
79
Antibiotics for acute rhinosinusitis
80
Antibiotics for acute rhinosinusitis – Authorʹs reply
81
Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data
82
Antibiotics for adverse outcomes of pregnancy
83
Antibiotics for adverse outcomes of pregnancy
84
Antibiotics for neurological ailments?
85
Antibiotics for patients with zygomatic fractures into the maxillary antrum
86
Antibiotics for preterm prelabour rupture of membranes and preterm labour?
87
ANTIBIOTICS FOR PROPHYLAXIS OF PLASMODIUM FALCIPARUM INFECTIONS: IN VITRO ACTIVITY OF DOXYCYCLINE AGAINST SENEGALESE ISOLATES
88
Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT
89
Antibiotics for severe chronic obstructive pulmonary disease
90
Antibiotics for sinusitis-like symptoms in primary care
91
Antibiotics for Spinal Cord Stimulation Trials and Implants: A Survey Analysis of Practice Patterns
92
Antibiotics for the common cold
93
Antibiotics for the common cold
94
Antibiotics for the common cold
95
Antibiotics for the common cold
96
Antibiotics for the Treatment of Leptospirosis: Systematic Review and Meta-analysis of Controlled Trials
97
Antibiotics for the uncommon cold
98
Antibiotics for vascular diseases: a meta-analysis of randomized controlled trials
99
Antibiotics from Australian terrestrial invertebrates. Part 1: Antibacterial trinervitadienes from the termite Nasutitermes triodiae
100
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: Chemical derivatization
101
Antibiotics in acute bronchitis
102
Antibiotics in acute bronchitis: a meta-analysis
103
Antibiotics in acute necrotising pancreatitis
104
Antibiotics in acute necrotising pancreatitis – Authorsʹ reply
105
Antibiotics in Acute Necrotizing Pancreatitis — Perspective of a Developing Country
106
Antibiotics in childhood acute otitis media
107
Antibiotics in Iranian Aquaculture Industry
108
Antibiotics in preterm labour
109
Antibiotics in preterm labour
110
Antibiotics in preterm labour—the ORACLE speaks
111
Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension
112
Antibiotics in the Hong Kong metropolitan area: Ubiquitous distribution and fate in Victoria Harbour
113
Antibiotics in the human food chain: Establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora
114
Antibiotics in the preservation of allograft and xenograft skin
115
Antibiotics in the prevention of heart attacks
116
Antibiotics in typical marine aquaculture farms surrounding Hailing Island, South China: Occurrence, bioaccumulation and human dietary exposure
117
Antibiotics in Upper Respiratory Tract Infections:Appropriateness of the Practice in Jordan
118
Antibiotics increase risk of intestinal problems in infants
119
Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome.
120
Antibiotics or surgery for vesicoureteric reflux in children
121
Antibiotics plus granulocyte colony-stimulating factor reduces febrile neutropenia in the first cycle of chemotherapy in people with small-cell lung cancer
122
Antibiotics Prescription Pattern and their Financial Burden before and after Intervention in Traumatic Injuries
123
Antibiotics production of cellulosic waste with solid state fermentation by Streptomyces
124
Antibiotics prophylaxis in surgery. Part 1: gastroenterological surgeries
125
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
126
Antibiotics Removal in Biological Sewage Treatment Plants
127
Antibiotics Removal in Biological Sewage Treatment Plants
128
Antibiotics rescue neurons from glutamate attack
129
antibiotics resistance pattern of staphylococcus aureus isolated from in-patients of an orthopaedic hospital in north- western nigeria
130
Antibiotics Resistance Profiling and In-Vitro Inhibition of Clinical Klebsiella Strains by Actinomycetes Isolated From Different Ecological Niches in Pakistan
131
Antibiotics resistant Escherichia coli from hospital liquid waste
132
Antibiotics Should be Given Only to Patients with Moderate-To-Severe COPD
133
Antibiotics Susceptibility Commonality for Community Acquired Methicillin-Resistant Staphylococcus aureus vs Hospital Acquired Methicillin-Resistant Staphylococcus aureus
134
Antibiotics susceptibility of E.cloacae and E.sakazakii that isolated from different clinical specimens
135
Antibiotics susceptibility of Escherichia coli isolates from clinical specimens before and during COVID-19 pandemic
136
Antibiotics to prevent infection of simple wounds: A meta-analysis of randomized studies
137
Antibiotics Use in Food-Producing Animals and Possible Residual Risk
138
Antibiotics Use Patterns for Surgical Prophylaxis Site Infection in Different Surgical Wards of a Teaching Hospital in Ahvaz, Iran
139
Antibiotics Use Patterns in Intensive Care Units of Five Hospitals in Tehran During 2011 - 2012
140
Antibiotics Utilization Pattern in a Children’s Medical Center in North of Iran
141
Antibiotics without prescription: “bacterial or medical resistance”?
142
Antibiotics, free radicals, and acute pancreatitis
143
Antibiotics, invention and innovation
144
Antibiotics: A New Hope Review Article
145
Antibiotics: unapproved uses or indications
146
Antibiotics-free stable polyhydroxyalkanoate (PHA) production from carbon dioxide by recombinant cyanobacteria
147
Antibiotyping and Genotyping of Pseudomonas aeruginosa Strains Isolated from Mottahari Hospital in Tehran, Iran by ERIC-PCR
148
Antibiotyping, RAPD- and ERIC-PCR fingerprinting of Klebsiella pneumoniae clinical isolates at a tertiary reference hospital in Denpasar, Bali, Indonesia
149
Anti-Bladder Cancer and Anti-Alzheimer Properties of Bavachin and Bavachinin as Natural Compounds with Molecular Docking and Dynamic Studies: In Vitro and in Silico Studies
150
Antiblocking decoding
151
Antiblocking systems and PD-sets Original Research Article
152
Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia
153
Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome
154
Antibodies against alpha-fodrin in Sjögrenʹs syndrome
155
Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels
156
Antibodies against Chlamydia pneumoniae in stable angina and interleukin-6 levels
157
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis
158
Antibodies against Leukocyte Function-Associated Antigen-1 and against Intercellular Adhesion Molecule-1 Together Suppress the Progression of Experimental Allergic Encephalomyelitis
159
Antibodies against murine double minute-2 (mdm2) in sera of patients with various gynaecological diseases
160
Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders
161
Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease
162
Antibodies against oxidized low-density lipoprotein in normolipidemic smokers
163
Antibodies against platelet-activating factor and platelet-activating factor–like lipids are raised in women with primary recurrent abortion
164
Antibodies Against Stress Proteins in Sera of Patients with Dilated Cardiomyopathy
165
Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis
166
Antibodies against the β1-adrenergic receptor induce progressive development of cardiomyopathy
167
Antibodies against TNF-α help close fistulas in Crohnʹs disease
168
Antibodies against Trypanosoma cruzi Alkaline Antigens Are Elicited in Sera from Acute but Not Chronic Human Chagasic Patients
169
Antibodies against Vibrio salmonicida lipopolysaccharide (LPS) and whole bacteria in sera from Atlantic salmon (Salmo salar L.) vaccinated during the smolting and early post-smolt period
170
Antibodies against viruses: passive and active immunization
171
Antibodies and antibody-based assays for hexavalent uranium
172
Antibodies and antibody-based assays for hexavalent uranium Original Research Article
173
Antibodies and gene therapy: teaching old ‘magic bullets’ new tricks
174
Antibodies and Genetically Engineered Related Molecules: Production and Purification
175
Antibodies and Immunoassays
176
Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides
177
Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides
178
Antibodies and primary biliary cirrhosis – piecing together the jigsaw
179
Antibodies and vaccines–hope or illusion?
180
Antibodies as effectors
181
Antibodies as effectors
182
Antibodies as pharmacologic tools for studies on the regulation of energy balance
183
Antibodies beyond the year 2000: Antibody Fusion Proteins edited by S.M. Chamow and A. Ashkenazi
184
Antibodies Binding Granulocyte–Macrophage Colony Stimulating Factor Produced by Cord Blood-Derived B Cell Lines Immortalized by Epstein–Barr Virus in Vitro
185
Antibodies conjugated with new highly luminescent Eu3+ and Tb3+ chelates as markers for time resolved immunoassays. Application to simultaneous determination of clenbuterol and free cortisol in horse urine
186
Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells
187
Antibodies effective against scrapie infection, report European researchers
188
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis
189
Antibodies for immunosensors a review
190
Antibodies in proteomics I: generating antibodies
191
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications
192
Antibodies in viral infection. Current topics in Microbiology and Immunology: Edited by DR Burton, Springer-Verlag Book Review Department, Tiergartenstrasse 17, 69121 Heidelberg, Germany. ISBN No.: 3-540-41611-0. Price: $115.00
193
Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension
194
Antibodies recognizing both IgM isotypes in Atlantic salmon
195
Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry
196
Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry
197
Antibodies that stop the adrenals in their tracks
198
Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas
199
Antibodies to actin in autoimmune haemolytic anaemia
200
Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta-glycoprotein I (beta2-GPI) in systemic lupus erythematosus
201
Antibodies to Aeromonas salmonicida Lipopolysaccharide and cell wall antigens in rabbit and salmon immune sera
202
Antibodies to amyloid β protein (Aβ) crossreact with glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
203
Antibodies to Block Staph Virulence
204
Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris
205
Antibodies to Chlamydia pneumoniae are related to the intima-media thickness in the carotid artery and to an atherogenetic fatty acid profile
206
Antibodies to Chlamydia pneumoniae react non-specifically with lipid on macrophages in human atherosclerotic arteries
207
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris
208
Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope
209
Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease
210
Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease
211
Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease
212
Antibodies to cytoplasmic dynein heavy chain map the surface and inhibit motility
213
Antibodies to E1 and E2/Protein X components of pyruvate dehydrogenase complex in sera of patients with primary biliary cirrhosis
214
Antibodies to endostatin in a multifocal glioblastoma patient
215
Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients
216
Antibodies to HTLV-I in Sjögrenʹs syndrome
217
Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk
218
Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA
219
Antibodies to human herpesvirus type 8 in the general population and in Kaposiʹs sarcoma patients
220
Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer
221
Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis
222
Antibodies to interleukin-8 and paraneoplastic catastrophic recurrent thromboses
223
Antibodies to intimin and Escherichia coli-secreted proteins EspA and EspB in sera of Brazilian children with hemolytic uremic syndrome and healthy controls
224
Antibodies to intimin and Escherichia coli-secreted proteins EspA and EspB in sera of Brazilian children with hemolytic uremic syndrome and healthy controls
225
Antibodies to lipopolysaccharides of Escherichia coli serogroups 05 and 0165 in healthy adults Original Research Article
226
Antibodies to Murine CD40 Protect Normal and Malignant B Cells from Induced Growth Arrest
227
Antibodies to Murine CD40 Stimulate Normal B Lymphocytes but Inhibit Proliferation of B Lymphoma Cells
228
Antibodies to Myelin Basic Protein in Children with Autistic Behavior
229
Antibodies to Oxidized LDL and LDL-Containing Immune Complexes as Risk Factors for Coronary Artery Disease in Diabetes Mellitus
230
Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy
231
Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy
232
Antibodies to Selected Canine Pathogens and Infestation with Intestinal Helminths in Golden Jackals (Canis aureus) in Israel
233
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis
234
Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis
235
ANTIBODIES TO SULFATIDE IN LEPROSY AND LEPROSY REACTIONS
236
Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection
237
Antibodies to the chlamydial 60 kd heat-shock protein are associated with laparoscopically confirmed perihepatitis, , ,
238
Antibodies to the Nonnative Forms of d-Glyceraldehyde-3-Phosphate Dehydrogenase: Identification, Purification, and Influence on the Renaturation of the Enzyme
239
Antibodies to Three Chondroitin Sulfate-Containing Proteoglycans in Squid Skin Recognize Hexa- or Longer Chondroitin Oligosaccharides as Major Antigenic Determinants
240
Antibodies to tumour necrosis factor α as treatment for Crohnʹs disease
241
Antibodies to varicella-zoster virus in blood donors with genetic variance in CC chemokine receptor 5
242
Antibodies to β2-glycoprotein-I: Relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus
243
Antibodies to βIΣ2 spectrin identify in-homogeneities in the erythrocyte membrane skeleton
244
Antibodies with specificities for d-xylose and for d-galacturonic acid residues of flaxseed polysaccharides Original Research Article
245
Antibodies, Fc receptors and cancer
246
Antibody Affinities and Relative Titers in Polyclonal Populations: Surface Plasmon Resonance Analysis of anti-DNA Antibodies
247
Antibody affinity purification using metallic nickel particles
248
Antibody against a novel, myriocin (ISP-I)-Based immunosuppressant, FTY720
249
Antibody against Interferon-a 2b in Serum of the Patients with ChronicHepatitis C and its Clinical Significance: A Clinical Trial
250
Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease
251
Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus
252
Antibody against Porcine Parvovirus VP2 Protein Differentiated This Virus from Other Viruses
253
Antibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptor
254
Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies
255
Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies
256
Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants
257
Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants
258
Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP)
259
Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP)
260
Antibody and cytokine responses to house dust mite allergens and Toxoplasma gondii antigens in atopic and non-atopic Brazilian subjects
261
Antibody and DNA dual-labeled gold nanoparticles: Stability and reactivity
262
Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
263
Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
264
Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
265
Antibody and skin-test responses of sheep vaccinated against Johneʹs Disease
266
Antibody and skin-test responses of sheep vaccinated against Johneʹs Disease
267
Antibody anti-H5N1 detection in poultry farmers and workers in poultry collection facilities in Indonesia, 2007
268
Antibody arrays for quantitative immunophenotyping
269
Antibody binding and functional properties of whey protein hydrolysates obtained under high pressure
270
Antibody binding on LiNbO3:Zn waveguides for biosensor applications
271
Antibody Binding to a Peptide but Not the Whole Protein by Recognition of the C-Terminal Carboxy Group
272
Antibody binding to porcine sialoadhesin reduces phagocytic capacity without affecting other macrophage effector functions
273
Antibody binding to Streptococcus mitis and Streptococcus oralis cell fractions
274
Antibody Buffering in the Brain
275
Antibody capture by mixed-mode chromatography: A comprehensive study from determination of optimal purification conditions to identification of contaminating host cell proteins
276
Antibody Capture Immunoassay for the Detection of Permethrin Carboxylesterase in Colorado Potato Beetle, Leptinotarsa decemlineata Say
277
Antibody catalyzed hydrolysis of a phosphotriester
278
Antibody catalyzed hydrolysis of a quorum sensing signal found in Gram-negative bacteria
279
Antibody cocktails: next-generation biopharmaceuticals with improved potency
280
Antibody Conjugated Gold Nanoparticles for Detection of Small Amounts of Antigen Based on Surface Plasmon Resonance (SPR) Spectra
281
Antibody Conjugation of Acoustically Reflective Liposomes for Tissue Targeting
282
Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
283
Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
284
Antibody detection against Leishmania infantum in sera of companion cats in Ahvaz, south west of Iran
285
Antibody detection of feline infectious peritonitis virus (FIPV) in sera of companion cats in Ahvaz, south west of Iran
286
Antibody Detection to Feline Immunodeficiency virus (FIV) in stray cats in Ahvaz, southwestern Iran
287
Antibody Detection to Feline Immunodeficiency virus (FIV) in stray cats in Ahvaz, southwestern Iran
288
Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma
289
Antibody Dynamics in Childhood Diseases: Waning and Boosting of Immunity and the Impact of Vaccination
290
Antibody Elbow Angles are Influenced by their Light Chain Class
291
Antibody engineering
292
Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy
293
Antibody Evolution from the Centre to the Periphery: Applied to a Human Antibody Fragment Recognising the Tumour-associated Antigen Mucin-1
294
Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity
295
Antibody immobilisation on the metal and silicon surfaces. The use of self-assembled layers and specific receptors
296
Antibody immobilization on a nanoporous aluminum surface for immunosensor development
297
Antibody immobilization to high-performance liquid chromatography supports: Characterization of maximum loading capacity for intact immunoglobulin G and Fab fragments
298
Antibody immobilization to phospholipid polymer layer on gold substrate of quartz crystal microbalance immunosensor
299
Antibody increases phagocytosis and killing of Lactococcus garvieae by rainbow trout (Oncorhynchus mykiss, L.) macrophages
300
Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view
301
Antibody isotype profiles in serum and circulating antibody-secreting cells following mucosal and peripheral immunisations of sheep
302
Antibody isotype profiles in serum and circulating antibody-secreting cells following mucosal and peripheral immunisations of sheep
303
Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China
304
Antibody isotypes in sera of equine fetuses aborted due to Leptospira interrogans serovar pomona-type kennewicki infection
305
Antibody isotypes in sera of equine fetuses aborted due to Leptospira interrogans serovar pomona-type kennewicki infection
306
Antibody levels to recombinant tick calreticulin increase in humans after exposure to Ixodes scapularis (Say) and are correlated with tick engorgement indices
307
Antibody light chain-catalyzed hydrolysis of a hepatitis C virus peptide
308
Antibody mediated fluorescence enhancement of nucleoside analogue 1,3-diaza-2-oxophenoxazine (tC°)
309
Antibody mediated immunity — a missed opportunity in the fight against tuberculosis?
310
Antibody microarray for correlating cell phenotype with surface marker
311
Antibody microarray-based strategies for detection of bacteria by lectin-conjugated gold nanoparticle probes
312
Antibody Modeling: Implications for Engineering and Design
313
Antibody neutralization of TGF-β enhances the deterioration of collagen fascicles in a tissue-cultured tendon matrix with ex vivo fibroblast infiltration
314
Antibody production
315
Antibody production and development of a polarization fluoroimmunoassay for the herbicide triclopyr
316
Antibody production and development of a polarization fluoroimmunoassay for the herbicide triclopyr Original Research Article
317
Antibody production in autoimmune BXSB mice. 1. CD40L-expressing B cells need fewer signals for polyclonal antibody synthesis
318
Antibody production in sheep fed a diet containing brown seaweed
319
Antibody Production System Modulated by Oral Administration of Human Milk and TGF-β
320
Antibody production: Low dose immunogen vs. low incorporation hapten using salmeterol as a model Original Research Article
321
Antibody production: Polyclonal-derived biotherapeutics
322
Antibody profiling for the prognosis and diagnosis of multiple sclerosis in patients, compared with healthy subjects
323
Antibody Protection to Diphtheria in Geriatric Patients: Need for ED Compliance With Immunization Guidelines, ,
324
Antibody purification by affinity chromatography based on small molecule affinity ligands identified by SPR-based screening of chemical microarrays
325
Antibody Rapid Test Results in Emergency Medical Services Personnel during COVID-19 Pandemic; a Cross Sectional Study
326
Antibody reactivity to HPV E6 and E7 oncoproteins and early diagnosis of invasive cervical cancer
327
Antibody reactivity to the major fish allergen parvalbumin is determined by isoforms and impact of thermal processing
328
Antibody reactivity to the transmembrane protein of the caprine arthritis encephalitis virus correlates with severity of arthritis: no evidence for the involvement of epitope mimicry
329
Antibody reactivity to the transmembrane protein of the caprine arthritis encephalitis virus correlates with severity of arthritis: no evidence for the involvement of epitope mimicry
330
Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII
331
Antibody recognition of an 18 kDa protein possibly involved in phosphate removal by activated sludge
332
Antibody recognition of epitopes on wild-type and mutant β-(1⃗4)-galactosyltransferase-1
333
Antibody recognition of picornaviruses and escape from neutralization: a structural view
334
Antibody response after immunization as a potentialindirect marker for improved resistance against furunculosis
335
Antibody response against hydatid fluid, protoscolex and whole body of Echinococcus granulosus antigens in lambs
336
Antibody response and protection of Atlantic salmon (Salmo salar) immunised with an extracellular polysaccharide ofAeromonas salmonicida
337
Antibody response in Hamsters Immunized against experimental Leishmaniasis
338
Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil
339
Antibody response in salmonids against the 70 kDa serine protease of Aeromonas salmonicida studied by a monoclonal antibody-based ELISA
340
Antibody response in salmonids against the 70 kDa serine protease of Aeromonas salmonicida studied by a monoclonal antibody-based ELISA
341
Antibody response in sheep experimentally infected with different small ruminant lentivirus genotypes
342
Antibody response in sheep experimentally infected with different small ruminant lentivirus genotypes
343
Antibody Response is Differentially Influenced by PLGA-PAD4 Particle Characteristics
344
Antibody Response of Murine B1 Cells to Hen Eggwhite Lysozyme
345
Antibody response to a filarial antigen fraction in individuals exposed to Wuchereria bancrofti infection in India
346
Antibody response to a fragment of the protein G of VHS rhabdovirus in immunised trout
347
Antibody response to a fragment of the protein G of VHS rhabdovirus in immunised trout
348
Antibody response to a sterile filtered PPD tuberculin in M. bovis infected and M. bovis sensitized cattle
349
Antibody Response to DT–GM, a Novel Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT) Linked to Human Granulocyte–Macrophage Colony Stimulating Factor (GM), during a Phase I Trial of Patients with Relapsed or Refractory Acute Myeloid Leukemia
350
Antibody response to glycan antigens of hydatid cyst fluid, laminated layer and protoscolex of Echinococcus granulosus
351
Antibody response to hepatitis b immunization in Egyptian children with sickle cell disease
352
Antibody response to hepatitis B vaccine among haemodialysis patients
353
Antibody Response to Human Extracellular HER2 Subdomain Proteins in Mice
354
ANTIBODY RESPONSE TO RECOMBINANT HEPATITIS B SURFACE ANTIGEN IN HEALTHY ADULTS FOLLOWING PRIMARY an‎d SUPPLEMENTARY VACCINATION
355
Antibody response to Staphylococcal slime and lipoteichoic acid
356
Antibody response to Staphylococcal slime and lipoteichoic acid
357
Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil
358
Antibody response to vaccination is enhanced by eccentric exercise in women but not in men
359
Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients
360
Antibody responses against non-structural protein 3 of bovine viral diarrhoea virus in milk and serum samples from animals immunised with an inactivated vaccine
361
Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens
362
Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens
363
Antibody responses by chinook salmon (Oncorhynchus tshawytscha) and rainbow trout (Oncorhynchus mykiss) to various protein antigens
364
Antibody responses in pregnancy-induced transmammary transmission of Ancylostoma caninum hookworm larvae
365
Antibody responses in pregnancy-induced transmammary transmission of Ancylostoma caninum hookworm larvae
366
Antibody responses in the serum and gut of chicken lines differing in cecal carriage of Salmonella enteritidis
367
Antibody responses in the serum and gut of chicken lines differing in cecal carriage of Salmonella enteritidis
368
Antibody responses of patients with cystic hydatid disease to recombinant myophilin of Echinococcus granulosus
369
Antibody responses of rainbow trout (Oncorhynchus mykiss, Walbaum) to liveAeromonas hydrophilaas assessed by various antigen preparations
370
Antibody Responses to Allergen Lol pIV Are Suppressed Following Adoptive Transfer of B Lymphocytes from the Internal Image Anti-idiotypic Antibody-Treated Mice
371
Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals
372
Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16
373
Antibody responses to inactivated vaccines and natural infection in cattle using bovine viral diarrhoea virus ELISA kits: Assessment of potential to differentiate infected and vaccinated animals
374
Antibody responses to Plasmodium falciparum vaccine candidate antigens in three areas distinct with respect to altitude
375
ANTIBODY RESPONSES TO PLASMODIUM FALCIPARUM: EVOLUTION ACCORDING TO THE SEVERITY OF A PRIOR CLINICAL EPISODE AND ASSOCIATION WITH SUBSEQUENT REINFECTION
376
Antibody responses to trivalent influenza vaccine in Iranian adults infected with human immunodeficiency virus.
377
Antibody separation by hydrophobic charge induction chromatography
378
Antibody specific to 43 kDa excretory–secretory antigenic peptide of Taenia solium metacestode as a potential diagnostic marker in human neurocysticercosis
379
Antibody specificities of children living in a malaria endemic area to inhibitory and blocking epitopes on MSP-119 of Plasmodium falciparum
380
Antibody therapy for non-Hodgkinʹs B-cell lymphoma proves itself
381
Antibody Titer Against Porphyromonas Gingivalis in Rats with Experimentally Induced Periodontitis
382
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis
383
ANTIBODY TITERS IN ANIMAL BITE VICTIMS AFTERPOST EXPOSURE VACCINATION WITH INTRADERMALLY ADMINISTERED PURIFIED VERO CELL RABIES VACCINE USING MODIFIED THAI RED CROSS REGIMEN
384
Antibody Titers to Hepatitis B Surface Antigen Among Vaccinated Emergency Physicians: Three Years’ Experience With a Wellness Booth, , , ,
385
Antibody to Haemophilus influenzae type b after routine and catch-up vaccination
386
Antibody to hepatitis C virus in patients with chronic hepatitis B virus infection
387
Antibody to Hsp70 alters response of rabbit preimplantation embryos to hyperthermia in vitro
388
Antibody to ovalbumin and delayed-type hypersensitivity to Candida albicans and mycobacteria in lactating Holstein cows using Quil A or Freundʹs complete adjuvant
389
Antibody to ovalbumin and delayed-type hypersensitivity to Candida albicans and mycobacteria in lactating Holstein cows using Quil A or Freundʹs complete adjuvant
390
Antibody tracing,seroepidemiology and risk factors of bovine respiratory syncytial virus and bovine adenovirus-3 in dairy Holstein farms
391
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
392
Antibody, complement and accommodation in ABO-incompatible transplants
393
Antibody/antigen affinity behavior in liquid environment with electrical impedance analysis of quartz crystal microbalances Original Research Article
394
Antibody–antigen binding study using size-exclusion liquid chromatography
395
Antibody-array technique reveals overexpression of important DNA-repair proteins during cardiac ischemic preconditioning
396
Antibody-Based fluorescence detection of kinase activity on a peptide array
397
Antibody-based fusion proteins to target death receptors in cancer
398
Antibody-based immobilization of bioluminescent bacterial sensor cells
399
Antibody-based immunological therapies
400
Antibody-Based Immunotherapy of Cancer
401
ANTIBODY-BASED PATHOGEN RESISTANCE IN PLANTS INVITED REVIEW
402
Antibody-based surfaces: Rapid characterization using two complementary colorimetric assays Original Research Article
403
Antibody-based therapy of non-Hodgkinʹs lymphoma
404
Antibody-catalyzed cleavage of the -Ala- -Lac depsipeptide: An immunological approach to the problem of vancomycin resistance
405
Antibody-catalyzed oxidative degradation of nicotine using riboflavin Original Research Article
406
Antibody-catalyzed water oxidation: state-of-the-art immunity or ancient history?
407
Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways
408
Antibody–cytokine fusion proteins
409
Antibody-Cytokine Fusion Proteins: Harnessing the Combined Power of Cytokines and Antibodies for Cancer Therapy
410
Antibody-Dependent Cell-Mediated Cytotoxicity Can Protect PBMC from Infection by Cell-Associated HIV-1
411
Antibody-dependent enhancement of HSV-1 infection by anti-gK sera
412
Antibody-dependent enhancement of infection: bacteria do it too
413
Antibody-dependent enhancement of PRRSV infection down-modulates TNF-α and IFN-β transcription in macrophages
414
Antibody-dependent enhancement of PRRSV infection down-modulates TNF-α and IFN-β transcription in macrophages
415
Antibody-directed cell-type-specific delivery of siRNA
416
Antibody-directed therapies for hematological malignancies
417
Antibody-DM1 conjugates as cancer therapeutics
418
Antibody-Drug Conjugates: Possibilities and Challenges
419
Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells
420
Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines
421
Antibody-Independent Protective Mucosal Immunity to Gastric Helicobacter Infection in Mice
422
Antibody-Induced CD3–CD4 Coligation Inhibits TCR/CD3 Activation in the Absence of Costimulatory Signals in Normal Mouse CD4+ T Lymphocytes
423
Antibody-Induced Oligomerization and Activation of an Engineered Reporter Enzyme
424
Antibody-mediated Immune Enhancement in Coxsackievirus B3 Myocarditis
425
Antibody-mediated platelet phagocytosis by human macrophages is inhibited by siRNA specific for sequences in the SH2 tyrosine kinase, Syk
426
Antibody-mediated regio- and enantioselective resolution of a glycerol derivative
427
Antibody-mediated regulation of cellular immunity and the inflammatory response
428
ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
429
Antibody-mediated rejection: importance of lactate dehydrogenase and neutrophilia in early diagnosis.
430
Antibody-producing cells correlated to body weight in juvenile chinook salmon (Oncorhynchus tshawytscha) acclimated to optimal and elevated temperatures
431
Antibody-targeted chemotherapy of acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg)
432
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury
433
Antibody-targeted photodynamic therapy
434
Anti-bombing insensitivity life of molybdenum cathode doped with La2O3 and Y2O3
435
Anti-bonding driving caused by electron emission: halogen desorption from Si surfaces
436
Anti-bovine CD34 monoclonal antibody reveals polymorphisms within coding region of the CD34 gene
437
Antibracket as the Hamiltonian structure of a supersymmetric KP hierarchy
438
Antibrackets, supersymmetric σ-model and localization
439
Anti-brain antibodies in adult patients with obsessive–compulsive disorder
440
Anti-branding on the internet
441
Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK) Original Research Article
442
Antibrowning activity of MRPs in enzyme and fresh-cut apple slice models
443
Antibrowning potential of Brassicacaea processing water
444
Antibubble and prediction of Chinaʹs stock market and real-estate
445
Antibubble lifetime: Influence of the bulk viscosity and of the surface modulus of the mixture
446
Antibubbles, liquid onions and bouncing droplets
447
Antibubbles: Factors that affect their stability
448
Anti-BVDV Activity Evaluation of Naphthoimidazole Derivatives Compared with Parental Imidazoquinoline Compounds
449
Anti‑C1q antibodies as a marker for disease activity in systemic lupus erythematosus and lupus nephritis
450
Anti-C1q autoantibodies
451
Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6
452
Anti-CagA IgG Antibody is Independent from Helicobacter pylori vacA and cagA Genotypes
453
Anti-caking in the production of titanium dioxide using low-grade titanium slag via the NaOH molten salt method
454
Anticalcification and antiresorption effects of bisacylphosphonates
455
Anticalins versus antibodies: made-to-order binding proteins for small molecules Original Research Article
456
Anti-Campylobacter, anti-aerobic, and anti-oxidative effects of roselle calyx extract and protocatechuic acid in ground beef
457
Anticancer action of black and green teas
458
Anticancer activities and mechanism of action of 2 novel metal complexes, C16H34N8O5Ag2Cd and C11H16N7O2Ag3Ni
459
Anticancer activities of a chemically sulfated polysaccharide obtained from Grifola frondosa and its combination with 5-Fluorouracil against human gastric carcinoma cells
460
Anticancer activities of constituents from the stem of Polyalthia rumphii
461
Anticancer activities of novel chalcone and bis-chalcone derivatives Original Research Article
462
ANTICANCER ACTIVITIES OF PHENOLIC COMPOUNDS FROM RED ROOMY GRAPE FRUITS AND ITS LEAVES EXTRACTS
463
Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives Original Research Article
464
Anticancer Activities of Styrylpyrone from the Leaves and Twigs of Goniothalamus maewongensis via Cell Cycle Arrest
465
Anticancer Activity a of Caspian Cobra (Naja naja oxiana) snake Venom in Human Cancer Cell Lines Via Induction of Apoptosis
466
Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides
467
Anticancer activity and mediation of apoptosis in human HL-60 leukaemia cells by edible sea cucumber (Holothuria edulis) extract
468
Anticancer activity for 4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and Their abilities to interact with lymphoendothelial cell surface markers
469
Anticancer activity in vitro of a fucoidan from the brown alga Fucus evanescens and its low-molecular fragments, structurally characterized by tandem mass-spectrometry
470
Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies
471
Anticancer activity of 3-O-acyl and alkyl-(−)-epicatechin derivatives
472
Anticancer activity of a ceramide analog containing a disulfide linkage
473
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane
474
Anti-cancer Activity of Allium jesdianum Extract Loaded on Microemulsions on Colon Cancer Cells Through Suppression of Autophagy and Activation of Necroptosis Process
475
Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor
476
Anticancer activity of Astragalus ovinus against 7, 12 dimethyl benz (a) anthracene (DMBA)-induced breast cancer in rats
477
Anticancer activity of cow, sheep, goat, mare, donkey and camel milks and their caseins and whey proteins and in silico comparison of the caseins
478
Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene
479
Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene
480
Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells
481
Anticancer activity of Cyathula prostrata (Linn) Blume against Dalton’s lymphomae in mice model
482
anticancer activity of delphinium semibarbatum alkaloid fractions against lncap, and du 145 human prostate cancer cells through the intrinsic apoptotic pathway
483
Anticancer activity of Doxorubicin conjugated to polymer/carbon based-nanohybrid against MCF-7 breast and HT-29 colon cancer cells
484
Anticancer Activity of Doxorubicin Loaded PBMA-b-POEGMA Micelles against MCF7 Breast Cancer Cells and HepG2 Liver Cancer Cells
485
Anticancer activity of ethanolic extract of propolis on AGS cell line
486
Anticancer Activity of Ethnopharmacological Plants of Golestan Province/Iran against AGS, HT-29 and KYSE-30 Cell Lines through Promoting the Apoptosis and Immunomodulatory Effects
487
Anticancer activity of Ficus religiosa engineered copper oxide nanoparticles
488
Anticancer activity of FTY720: Phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D
489
Anticancer activity of grape and grape skin extracts alone and combined with green tea infusions
490
Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells
491
Anticancer Activity of Hydatid Cyst Fluid along with Antigen B on Tumors Induced by 4T1 Breast Cancer Cell in a BALB/c Mice Model
492
Anticancer Activity of Indigofera aspalathoides and Wedelia calendulaceae in Swiss Albino Mice
493
Anticancer Activity of Kefir on Glioblastoma Cancer Cell as a New Treatment
494
Anticancer Activity of Limonia acidissima Linn (Rutaceae) Fruit Extracts on Human Breast Cancer Cell Lines
495
Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells
496
Anti-Cancer Activity of Methanol Extracts of Cichorium Intybus on Human Breast Cancer SKBR3 Cell Line
497
Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction
498
Anticancer activity of multinuclear arene ruthenium complexes coordinated to dendritic polypyridyl scaffolds
499
Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation
500
anticancer activity of new 3-secondary amine derivatives containing fused rings of the imidazopyridine
501
Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand
502
Anticancer activity of novel ruthenium complex with 1,10-phenanthrolineselenazole as potent telomeric G-quadruplex inhibitor
503
Anticancer Activity of Polyisoprenoids from Avicennia alba Blume. in WiDr Cells
504
Anticancer activity of polyoxomolybdate
505
Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
506
Anticancer activity of Pupalia lappacea on chronic myeloid leukemia K562 cells
507
Anticancer activity of silver nanoparticles synthesized from aqueous leaf extract of Solanum trilobatum (Purple fruit pea eggplant) on human oral cancer cells
508
Anticancer Activity of Some New Synthesized Tetrahydroquinoline and Tetrahydrochromene Carbonitrile Derivatives
509
Anticancer Activity of Sunflower (Helianthus annuns L.) Seeds oil against cell lines
510
Anticancer activity of synthetic analogues of the phorboxazoles
511
Anticancer activity of the roots of Ichnocarpus frutescens R. Br. and isolated triterpenes
512
Anticancer activity, structure, and theoretical calculation of N-(1-phenyl-3-methyl-4-propyl-pyrazolone-5)-salicylidene hydrazone and its copper(II) complex
513
Anticancer and antibacterial activities of embelin: micro and nano aspects
514
Anticancer and Antibacterial Effect of Eucalyptus Camaldulensis, in Vitro
515
Anti-cancer and Anti-bacterial Effects of Bioactive Compounds of Scutellaria Species
516
Anticancer and Antibacterial Properties in Peptide Fractions from Hydrolyzed Spirulina Protein
517
Anticancer and antifungal activity of copper(II) complexes of quinolin-2(1H)-one-derived Schiff bases
518
Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives
519
Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana
520
Anti-cancer and antioxidant activities of some new synthesized 3-secondary amine derivatives bearing imidazo [1,2-A] pyrimidine
521
Anticancer and Antioxidant Activity by Secondary Metabolites of Aspergillus fumigatus
522
Anticancer and antioxidant activity of synthetic chalcones and related compounds
523
Anticancer and Antioxidant Properties of Ag NPs Coated with BSA NPs
524
Anticancer and antiviral agents: Including Therapy Monitoring and Diagnostic Marker Aspects
525
Anticancer and Apoptotic Effects of Ectoine and Hydroxyectoine on NonSmall Cell Lung Cancer cells: An invitro Investigation
526
Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line
527
Anticancer and Biochemical Effects of Calcium Chloride on Ehrlich Carcinoma Cell-Bearing Swiss Albino Mice
528
Anticancer and superoxide scavenging activities of p-alkylaminophenols having various length alkyl chains Original Research Article
529
Anticancer butanolides and lignans from the Makko tree, Machilus thunbergii Siebold Zucc. (Lauraceae). A review
530
Anticancer Drug Delivery Shuttles based on Polyethylene Glycol-polylactic Acid Nanocomposites: Molecular Dynamics Simulations
531
Anticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizer Original Research Article
532
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
533
Anticancer drug-layered hydroxide nanohybrids as potent cancer chemotherapy agents Original Research Article
534
Anticancer drugs and central nervous system: Clinical issues for patients and physicians
535
Anticancer drugs based on alkenyl and boryl substituted titanocene complexes
536
Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29
537
Anticancer Effect of Bovine Lactoferrin on Breast Cancer Cell Line MCF7 and the Evaluation of Bax and Bak Genes Expression Involved in Apoptosis
538
Anticancer Effect of Bovine Lactoferrin on Human Esophagus Cancer Cell Line
539
Anti-Cancer Effect of Bromelain and Its Combination with Cisplatin on HN5 Cell Line (Squamous Cell Carcinoma)
540
Anticancer Effect of Carob Bean Extract on Human Prostate Cancer Cell Lines: Apoptosis Induction and Bax/Bcl-2 Ratio Improvement
541
Anti-cancer effect of Cordyceps militaris in human colorectal carcinoma RKO cells via cell cycle arrest and mitochondrial apoptosis
542
Anti-Cancer Effect of Dorema Ammoniacum Gum by Targeting Metabolic Reprogramming by Regulating APC, P53, KRAS Gene Expression in HT-29 Human Colon Cancer Cells
543
Anticancer effect of Dunaliella salina under stress and normal conditions against skin carcinoma cell line A431 in vitro
544
Anticancer Effect of Enterococcus faecium, Isolated from Vaginal Fluid, on Ovarian Cancer Cells
545
Anticancer Effect of Ferulago Mughlea Peşmen (Apiaceae) on Cancer Cell Proliferation
546
Anticancer Effect of Fluorouracil and Gum-Based Cerium Oxide Nanoparticles on Human Malignant Colon Carcinoma Cell Line (Caco2)
547
Anticancer Effect of Fractions From Staphylococcus aureus and Bacillus atrophaeus on the Proliferation and Death of Human Breast Cancer Cell Line (MCF-7)
548
Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer
549
Anti-cancer effect of ICD-85(venom derived peptides) on MDA-MB231 cell line (in vitro) and experimental mice with breast cancer (in vivo)
550
Anticancer effect of lactoferrin on Gastric Cancer Cell Line AGS
551
Anticancer effect of lactoferrin on Gastric Cancer Cell Line AGS
552
Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3
553
Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids
554
Anticancer effect of the IgY that produced against a small peptide with 15 amino acids of human DR5 on MCF7 cell line
555
Anticancer effect of underutilized fruits
556
Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells
557
Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo: Bylund A, Saarinen N, Zhang JX, Bergh A, Widmark A, Johansson A, Lundin E, Adlercreutz H, Hallmans G, Stattin P, Mنkel ن S, University of Turku, Functional Food
558
Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells
559
Anticancer Effects of Copper (II) Hydrazone Schiff Base Complex: A review
560
Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway
561
Anticancer effects of fenretinide in human medulloblastoma
562
Anti-cancer Effects of Ketoprofen on the Expression of HE4 Gene and Viability of the A2780 Human Ovarian Cancer Cell Line
563
Anticancer Effects of Melissa officinalis: A Traditional Medicine
564
Anticancer Effects of Moderate Static Magnetic Field on Cancer Cells In Vitro
565
Anti-cancer effects of nanoemulsion prepared using Zingiber Officinale L. tincture against PC3 prostate cancer cells
566
Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells
567
Anti-cancer Effects of Pomegranate Seed Oil on Esophageal Cancer Cell Line (KYSE-30)
568
Anti-Cancer Effects of Probiotic Lactobacillus acidophilus for Colorectal Cancer Cell Line Caco-2 through Apoptosis Induction
569
Anti-cancer effects of the extracts of broad and spirale cultivars of Codiaeum variegatum (L.) Blume on MCF-7, HepG2, and HeLa cell lines
570
Anticancer effects of Xi Huang Capsule on breast cancer in vivo
571
Anticancer Effects of ZnO/CNT@Fe3O4 in AML-Derived KG1 Cells: Shedding Light on Promising Potential of Metal Nanoparticles in Acute Leukemia
572
Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer
573
Anticancer Enzyme L-Lysine (alpha)-Oxidase
574
Anti-cancer gene therapy using genetically modified MSCs expressing HSV-TK with controlled gene expression by pro-drug GCV
575
Anticancer investigations on Carissa opaca and Toona ciliata extracts against human breast carcinoma cell line
576
Anticancer oral therapy: Emerging related issues
577
Anti-cancer PEG-enzymes: 30 years old, but still a current approach
578
Anticancer polysaccharides from natural resources: A review of recent research
579
Anticancer Potential of 3-O-Methylellagic Acid 3’-O-α-Ramnoside from Shorea Beccariana: In Silico Studies
580
Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity
581
Anticancer Potential of Fruit Extracts from Vatica diospyroides Symington Type SS and Their Effect on Program Cell Death of Cervical Cancer Cell Lines
582
Anticancer Potential of Phenolic Extract from Spirulina Platensis Against Esophagus Cancer Cells
583
Anticancer potential of Tinospora cordifolia and arabinogalactan against benzo(a)pyrene induced pulmonary tumorigenesis: a study in relevance to various biomarkers
584
Anticancer Properties for 4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007)/3,7-Diaminophenothiazin-5-ium Double Salts
585
Anticancer properties of a new platinum (IV) agent on HT1080 cancer stem-like cells: an in vitro study
586
Anticancer properties of chitosan against osteosarcoma, breast cancer and cervical cancer cell lines
587
Anti-Cancer Properties of Diethylether Extract of Wood from Sukun (Artocarpus altilis) in Human Breast Cancer (T47D) Cells
588
Anti-cancer properties of Escherichia coli Nissle 1917 against HT- 29 colon cancer cells through regulation of Bax/Bcl-xL and AKT/ PTEN signaling pathways
589
Anticancer Properties of Fluorinated Aminophenylhydrazines on A549 Lung Carcinoma Cell Line
590
Anticancer properties of Malaysian herbs: a review
591
Anti-cancer Properties of Myricetin Against HT-29 Colon Cancer Cells Through Regulation of RIPK1/RIPK3 Signaling Pathway
592
anti-cancer properties of nicotinic cid-alpha linolenic acid derivative on a375 melanoma cell line: assessment of apoptosis and wnt signaling pathways
593
Anti-cancer properties of phenolics from apple waste on colon carcinogenesis in vitro
594
Anti-cancer properties of the methanol extract of Boswellia serrata gum resin: Cell proliferation arrest and inhibition of angiogenesis and metastasis in BALB/c mice breast cancer model
595
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin Original Research Article
596
Anticancer Quinones Induce pRb-Preventable G2/M Cell Cycle Arrest and Apoptosis
597
Anticancer research: a few hints for discovery of new targets
598
Anti-cancer role of SPARC, an inhibitor of adipogenesis
599
Anticancer Screening of Various Seed Extract of Cardiospermum halicacabum on Human Colorectal, Skin and Breast Cancer Cell Lines
600
Anticancer therapeutic self-aggregates of sphingolipid metabolite-grafted poly(amino acid)-derivative and their enhanced intracellular delivery
601
Anticancer Therapy SMRT-ens Up: Targeting the BCL6-SMRT Interaction in B Cell Lymphoma
602
Anticancer therapy using glucuronate modified long-circulating liposomes
603
Anticancer thiopyrano[2,3-d][1,3]thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico-chemical properties, and computational studies Original Research Article
604
Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations
605
Anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects of bisdemethoxycurcumin: Micro and nano facets
606
Anticancer, antioxidant and antibiotic activities of mushroom Ramaria flava
607
Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel
608
Anticancer, antioxidant, and antibacterial effects of nanoemulsion of Origanum majorana essential oil
609
Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound Original Research Article
610
Anticancerous effects of Polygonum avicular exert through Fas ligand and Bcl2
611
Anti-Candida Activities and GC Mass Analysis of Seeds Hydroalcohlic Extract of Rumex obtusifolius
612
Anti-Candida albicans Properties of Novel Benzoxazine Analogues Original Research Article
613
Anticandidal activity of cell extracts from 13 probiotic Lactobacillus strains and characterisation of lactic acid and a novel fatty acid derivative from one strain
614
Anti-Candidal Effect of Shallot against Chronic Candidiasis
615
Anticandidal effects of aqueous and callus extracts of Artemisia aucheri
616
anticandidal effects of zinc oxide nanoparticles on fluconazole-resistant candida isolates causing diarrhea in calves, in vitro
617
Anticandidal Potential of Endophytic Bacteria Isolated from Dryopteris uniformis (Makino)
618
Anticandidosic Activity and Acute Toxicity of Quercus Suber L. Bark Extracts
619
Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum
620
Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum
621
Anti-Carbonic Anhydrase II Antibodies in End-Stage Renal Disease Patients
622
Anticarcinogenesis by dietary phytochemicals: Cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-κB and AP-1 in abnormal cancer cells
623
Anticarcinogenic Activity of Leptadenia reticulata against Dalton’s Ascitic Lymphoma
624
Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori
625
Anti-carcinogenic and anti-angiogenic properties of the extracts of Acorus calamus on gastric cancer cells
626
Anticarcinogenic effect of black tea on pulmonary tumors in Swiss albino mice
627
Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa
628
Anti-carcinogenic effects of Satureja khuzistanica and Zataria multiflora essential oils on K562 cell line proliferation
629
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells
630
Anticarcinogenic propertiesof garlic: A review
631
Anticarcinogenic propertiesof garlic: A review
632
Anticardiolipin and Antibeta2glycoproteinI Antibodies in Patients with Hepatitis B and C Infections
633
Anti-Cardiolipin and Anti-Neutrophil Cytoplasmic Antibodies in Iranian Patients with Behcet's Disease
634
Anticardiolipin and Antiphospholipid Antibodies in Iraqi Patients with Angina Pectoris
635
Anticardiolipin and Anti-β2-Glycoprotein-I Antibodies in Hypertensive Disorders of Pregnancy
636
Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: A controlled prospective study
637
Anti-cardiolipin antibodies and circulating immune complexes in type I diabetes mellitus: increased prevalence and relation to vascular complications
638
Anti-Cardiolipin Antibodies and Endothelial Function in Patients With Coronary Artery Disease
639
Anticardiolipin Antibodies and Immunoglobulin M and A in Graves Disease
640
Anticardiolipin Antibodies in Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus
641
Anticardiolipin Antibodies in Myelodysplastic Syndromes
642
Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor
643
Anticardiolipin antibodies in stroke patients in Sudan Appraisal of their significance in a region of high burden of endemic infections
644
Anticardiolipin antibodies in systemic lupus erythematosus: Clinical and laboratory correlations
645
Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy
646
Anticardiolipin Antibody in Patients with Behçetʹs Disease with and without Vascular Thrombosis
647
Anti-Cardiolipin, Anti-Cardiolipin Plus Bovine, or Human β2Glycoprotein-I and Anti-Human β2Glycoprotein-I Antibodies in a Healthy Infant Population
648
Anticaries effect of atraumatic restorative treatment with fissure sealants in suburban districts of Turkey
649
Anticariogenic and Hemolytic Activity of Selected Seed Protein Extracts In vitro conditions
650
Anticariogenic and phytochemical evaluation of Eucalyptus globules Labill.
651
Anti-cariogenic effect of a cetylpyridinium chloride-containing nanoemulsion
652
Anti-cariogenic effect of a cetylpyridinium chloride-containing nanoemulsion
653
Anticariogenic Properties of Solanum ferox L. Ethanol Extract
654
Anticausatives have no Cause(r): A rejoinder to
655
Anticausatives: Against reflexivization
656
Anti-CCR3 monoclonal antibody inhibits eosinophil infiltration in Angiostrongylus cantonensis-infected ICR mice
657
Anti-CD11b monoclonal antibody improves myocardial function after six hours of hypothermic storage
658
Anti-CD19 Monoclonal Antibodies: a New Approach to Lymphoma Therapy
659
Anti-CD2 Monoclonal Antibody-Induced Receptor Changes: II. Interaction of CD2 and CD3
660
Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.
661
Anti-CD20 antibody therapy is highly effective in the treatment of follicular lymphoma
662
Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders
663
Anti-CD200R Ameliorates Collagen-Induced Arthritis in Mice
664
Anti-CD24 bio Modified PEGylated Gold Nanoparticles as Targeted Computed Tomography Contrast Agent
665
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
666
Anti-CD2-Induced Tyrosine Phosphorylation of T Cell Polypeptides Is Independent of the PMA-Induced Modification of p56lck
667
Anti-CD3 antibody ameliorates experimental autoimmune uveitis by inducing both IL-10 and TGF-β dependent regulatory T cells
668
Anti-CD3 clinical trials in type 1 diabetes mellitus
669
Anti-CD3 mAb treatment cures PDL1−/−.NOD mice of diabetes but precipitates fatal myocarditis
670
Anti-CD3 priming generates heterogeneous antigen-specific memory CD4 T cells
671
Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways
672
Anti-CD3-Induced Anergy in Cloned Human Th0, Th1, and Th2 Cells
673
Anti-CD4 Monoclonal Antibodies Suppress Murine Collagen-Induced Arthritis Only at the Time of Primary Immunisation
674
Anti-CD40 allays rheumatoid arthritis in mice
675
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
676
Anticentromere Autoantibodies in Patients without Raynaudʹs Disease or Systemic Sclerosis
677
Anticestodal activity of the crude aqueous extract of pumpkin seed (Cucurbita pepo) against the dwarftapeworm (Hymenolepis nana) in mice
678
Anti-cheating 201: Preparing multiple versions of accounting exam problems through dynamic linking of word processing and spreadsheet programs
679
Antichlamydia IgG Antibody in Adult Asthmatics in Al-Najaf
680
Antichlamydial activity of vaginal secretion
681
Anticholesterol Activity of Velvet Bean (Mucuna pruriens L.) towards Hypercholesterolemic Rats
682
Anti-cholesterol antibodies (ACHA) in patients with different atherosclerotic vascular diseases and healthy individuals. Characterization of human ACHA
683
Anti-cholesterol antibodies in human sera
684
Anticholinergic drug use in elderly people: A populationbased study in Iran
685
Anticholinergic drug-induced delirium in an elderly alzheimerʹs dementia patient
686
Anticholinergic drugs and elderly people: a no brainer?
687
Anticholinergic poisoning in colicky infants treated with hyoscyamine sulfate
688
Anticholinergic poisoning with adulterated intranasal cocaine
689
Anticholinergic suppression of ovine fetal swallowing activity, , ,
690
Anticholinergic toxicity associated with lupine seeds as a home remedy for diabetes mellitus
691
Anticholinergic toxicity associated with the ingestion of lupini beans
692
Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review
693
Anticholinesterase and antioxidant activities of Savoury (Satureja thymbra L.) with identified major terpenes of the essential oil
694
Anticholinesterase and antioxidant effects of the ethanol extract, ethanol fractions and isolated flavonoids from Cistus laurifolius L. leaves
695
Anticholinesterase and Antityrosinase Activities of Ten Piper Species from Malaysia
696
Anti-cholinesterase and Neuroprotective Activities of Sweet and Bitter Apricot Kernels (Prunus armeniaca L.)
697
Anticholinesterase furocoumarins from Heracleum platytaenium, a species endemic to the Ida Mountains
698
Anticholinesterase potential of flavonols from paper mulberry (Broussonetia papyrifera) and their kinetic studies
699
Anticholinesterase Potential of Monoterpenoids on the Whitefly Bemisia tabaci and Their Kinetic Studies
700
Anticholinesterase, Antioxidant, Antiaflatoxigenic Activities of Ten Edible Wild Plants from Ordu Area, Turkey
701
Anti-chromatin (anti-nucleosome) antibodies: Diagnostic and clinical value
702
Anti-chromatin (anti-nucleosome) autoantibodies
703
Anticipate response of climate change on coastal risks at regional scale in Aquitaine and Languedoc Roussillon (France)
704
Anticipated and experienced stigma among people with schizophrenia: its nature and correlates
705
Anticipated and Unanticipated Difficult Airway: A Practical and Logical Approach; A Narrative Review
706
Anticipated backward stochastic differential equations driven by the Teugels martingales
707
Anticipated coastal impacts: What water-users think of marine renewables and why
708
Anticipated cooperation vs. competition moderates interpersonal projection
709
Anticipated dependence: A determinant in an integrative model of power relations among elderly couples
710
Anticipated difficult intubation due to intraoral lipomatous polyp
711
Anticipated fiscal policy and adaptive learning
712
Anticipated foreign military threat, arms accumulation, and the current account in a small open economy
713
Anticipated growth and business cycles in matching models
714
Anticipated growth and business cycles in matching models
715
Anticipated host availability increases parasitoid host attack behaviour
716
Anticipated identification costs: Improving assortment evaluation by diagnostic attributes
717
Anticipated inflation and rates of return in a search-theoretic monetary model
718
Anticipated inflation and rates of return in a search-theoretic monetary model$
719
Anticipated IT infrastructure and supply chain integration capabilities for RFID and their associated deployment outcomes
720
Anticipated Performance Index of some tree species considered for green belt development in and around an urban area: A case study of Varanasi city, India
721
Anticipated performance of free-fall lifeboats in a high wind environment
722
Anticipated performance of free-fall lifeboats in a high wind environment
723
Anticipated policy and endogenous growth in a small open monetary economy
724
Anticipated reliability of liquid Chemical Sterilants
725
Anticipated response to three common injuries by rural and remote area residents
726
Anticipated shaming and criminal offending
727
Anticipated socio-environmental impacts of the proposed Little Darby National Wildlife Refuge in Ohio
728
Anticipated specialties and influencing factors among final year medical students in a Nigerian University
729
Anticipated synchronization in coupled chaotic maps with delays
730
Anticipatedfiscalpolicyandadaptivelearning$
731
Anticipating a service experience
732
Anticipating action effects recruits audiovisual movement representations in the ventral premotor cortex
733
Anticipating aging failure using feedback data and expert judgment
734
Anticipating aging failure using feedback data and expert judgment
735
Anticipating and Executing off Beat Pregnancies in M #xFC;llerian Duct Anomalies: A Case Series
736
Anticipating and responding to obstetric emergencies
737
Anticipating bailouts: The incentive-conflict model and the collapse of the Ohio deposit guarantee fund
738
Anticipating catalytic oxidation reactions on gold at high pressure (including liquid phase) from ultrahigh vacuum studies
739
Anticipating ethical aspects of the use of biomarkers in the workplace: A tool for stakeholders
740
Anticipating Ethical Challenges: Is There a Coming Era of Nanotechnology?
741
Anticipating explanations in relative clause processing
742
Anticipating Flows on the Wiener Space Generated by Vector Fields of Low Regularity
743
Anticipating incoming events: an impaired cognitive process in schizophrenia
744
Anticipating intentional actions: The effect of eye gaze direction on the judgment of head rotation
745
Anticipating library use by business students: the uses of a syllabus study
746
Anticipating more anticipation
747
Anticipating reuse: documenting buildings for operations using web technology
748
Anticipating seizure: Pre-reflective experience at the center of neuro-phenomenology
749
Anticipating SMIL 2.0: the developing cooperative infrastructure for multimedia on the Web
750
Anticipating stochastic 2D Navier–Stokes equations
751
Anticipating Stochastic Differential Equations: Regularity of the Law
752
Anticipating stochastic differential systems with memory
753
Anticipating stochastic Volterra equations
754
Anticipating synchronization based on optical injection-locking in chaotic semiconductor lasers
755
Anticipating technological breakthroughs: Using bibliographic coupling to explore the nanotubes paradigm
756
Anticipating the Compressive Strength of Hydrated Lime Cement Concrete Using Artificial Neural Network Model
757
Anticipating the effect of The Patient Protection and Affordable Care Act for patients with urologic cancer
758
Anticipating the effect of The Patient Protection and Affordable Care Act for patients with urologic cancer
759
Anticipating the End: Thoughts on the Spectator and the Temporality of Dasein
760
Anticipating the friction coefficient of friction materials used in automobiles by means of machine learning without using a test instrument
761
Anticipating the future by counting DNA triplet repeats
762
Anticipating the Future in the Present: “New Women” and Other Beings of the Future in Weimar Germany
763
Anticipating the impact of new technologies on retailing
764
Anticipating the inevitable: When leader and member attribution styles clash
765
ANTICIPATING THE TSUNAMI: RUMOURS, PLANNING AND THE ARBITRARY STATE IN ZIMBABWE
766
Anticipating Urinary Retention Following Total Hip and Total Knee Replacements
767
Anticipation and execution of a simple reading task enhance corticospinal excitability
768
Anticipation and Imprinting in Schizophrenia
769
Anticipation and Prioritization of Green Jobs in Iran Using a Multi-Criteria Decision Analysis Method
770
Anticipation echoes in vintage capital models
771
Anticipation effect in pedestrian dynamics: Modeling and experiments
772
Anticipation effects of technological progress on capital accumulation: a vintage capital approach
773
Anticipation et dépressionAnticipation and depression.
774
Anticipation in familial cavernous angioma: a study of 52 families from International Familial Cavernous Angioma Study
775
Anticipation in innovative investment under oligopolistic competition
776
Anticipation in the synchronization of chaotic time-delay systems
777
Anticipation of aversive stimuli activates extended amygdala in unipolar depression
778
Anticipation of Aversive Visual Stimuli Is Associated With Increased Insula Activation in Anxiety-Prone Subjects
779
Anticipation of Currency Crisis in Iran Economy with the Use of an Early Warning System
780
Anticipation of epileptic seizures from standard EEG recordings
781
Anticipation of epileptic seizures from standard EEG recordings
782
Anticipation of epileptic seizures from standard EEG recordings
783
Anticipation of epileptic seizures from standard EEG recordings
784
Anticipation of epileptic seizures from standard EEG recordings
785
Anticipation of epileptic seizures from standard electro-encephalographic recordings
786
Anticipation of High-Sensitivity C-Reactive Protein Effect on Post Myocardial Infarction Depression Disorder
787
Anticipation of interoceptive threat in highly anxiety sensitive persons
788
Anticipation of migration and psychological stress and the Three Gorges Dam project, China
789
Anticipation of Public Speaking in Virtual Reality Reveals a Relationship Between Trait Social Anxiety and Startle Reactivity
790
Anticipation of somatosensory and motor events increases centro-parietal functional coupling: An EEG coherence study
791
Anticipation of Traffic Demands to Guarantee QoS in IP/Optical Networks
792
Anticipation skill and susceptibility to deceptive movement
793
Anticipations of Effort and Accuracy in Multiattribute Choice
794
Anticipative Diffusion and Related Change of Measures
795
Anticipative grid design in point-mass approach to nonlinear state estimation
796
Anticipative Markovian transformations on the Poisson space
797
Anticipative stochastic integration based on time-space chaos
798
Anticipatory activation of postural muscles associated with bilateral arm flexion in subjects with different quiet standing positions
799
Anticipatory and consummatory components of the experience of pleasure: A scale development study
800
Anticipatory assistance-as-needed control algorithm for a multijoint upper limb robotic orthosis in physical neurorehabilitation
801
Anticipatory attention during the sleep onset period
802
Anticipatory balance control is affected by loadless training experiences
803
Anticipatory coarticulation and aphasia: implications for phonetic theories
804
Anticipatory compliance and effective regulatory activity
805
Anticipatory conditioning of spelling-to-sound translation
806
Anticipatory control of head posture
807
Anticipatory distributed packet filter configurations for carrier-grade IP networks
808
Anticipatory effects of food exposure in women diagnosed with bulimia nervosa
809
Anticipatory effects of voluntary export restraints: a study of home video cassette recorders market, 1978–86
810
Anticipatory Electromyographic Activity and Onset Time in Selected Muscles of Lower Limb Between the Active and Inactive Old Women
811
Anticipatory emotions in decision tasks: Covert markers of value or attentional processes?
812
Anticipatory Governance
813
Anticipatory Grief Reactions in Fathers of Preterm Infants Hospitalized in Neonatal Intensive Care Unit
814
Anticipatory ʹʹitʹʹ lexical bundles: A comparative study of student and published writing in applied linguistics
815
Anticipatory iterative learning control for nonlinear systems with arbitrary relative degree
816
Anticipatory learning in two-person games: some experimental results
817
Anticipatory load shedding scheme for loadability enhancement
818
Anticipatory locomotor adjustments of the trail limb during surface accommodation
819
Anticipatory locomotor control for obstacle avoidance in mid-childhood aged children
820
Anticipatory looks reveal expectations about discourse relations
821
Anticipatory modeling of biocomplexity in the Tisza River Basin: First steps to establish a participatory adaptive framework
822
Anticipatory physiological regulation in feeding biology: Cephalic phase responses
823
Anticipatory postural adjustments associated with a forward leg raising in children: Effects of age, segmental acceleration and sensory context
824
Anticipatory postural adjustments associated with rotational perturbations while standing on fixed and free-rotating supports
825
Anticipatory postural adjustments during load catching by standing subjects
826
Anticipatory postural adjustments during standing in below-the-knee amputees
827
Anticipatory postural adjustments in a bimanual, whole body lifting task with an object of known weight
828
Anticipatory postural adjustments in a bimanual, whole-body lifting task seem not only aimed at minimising anterior–posterior centre of mass displacements
829
Anticipatory postural adjustments in conditions of simulated reduced gravity
830
Anticipatory postural adjustments modify the movement-related potentials of upper extremity voluntary movement
831
Anticipatory postural control following fatigue of postural and focal muscles
832
Anticipatory postural control strategies related to predictive perturbations
833
Anticipatory processes under academic stress: An ERP study
834
Anticipatory processing in social anxiety: two pilot studies
835
Anticipatory reflection while learning to teach: from a temporally truncated to a temporally distributed model of reflection in teacher education
836
Anticipatory response control in motor sequence learning: Evidence from stimulus–response compatibility
837
Anticipatory responses to perturbation of co-ordination in one-handed catching
838
Anticipatory routing of police helicopters
839
Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia
840
Anticipatory spatial representation of 3D regions explored by sighted observers and a deaf-and-blind-observer
841
Anticipatory Standards and the Commercialization of Nanotechnology
842
Anticipatory Stress: The Relation of Locus of Control, Optimism, and Control Appraisals to Coping
843
Anticipatory Symptoms and Anticipatory Immune Responses in Pediatric Cancer Patients Receiving Chemotherapy: Features of a Classically Conditioned Response?
844
Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses
845
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
846
Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis
847
Anticlastic curvature in draw-bend springback
848
Anticlastic effects and the transition from narrow to wide behavior in orthotropic beams
849
Anticlastogenic activity of cacao: inhibitory effect of cacao liquor polyphenols against mitomycin C-induced DNA damage
850
Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice
851
Anticlastogenic and antigenotoxic effects of selenomethionine on doxorubicin-induced damage in vitro in human lymphocytes
852
Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice
853
Anticlastogenic effects of centchroman and its enantiomers in Swiss albino mice. I. Acute study and their comparison with tamoxifen
854
Anti-Clastogenic Effects of Citral
855
Anticlastogenic potential of 1α,25-dihydroxyvitamin D3 in murine lymphoma
856
Anticlastogenic, radiation antagonistic, and anti-inflammatory activities of Persea americana in albino Wistar rat model
857
Anticline axes displacement between Fatha and Jeribe formation of structures In the south Hemreen area (Central Iraq ) from seismic evidence
858
Anticlines and synclines with hyperbolic density contrast and their gravity inversion
859
Anticlockwise evolution of ultrahigh-temperature granulites within continental collision zone in southern India
860
Anticoagulant activities of goby muscle protein hydrolysates
861
Anticoagulant activity of a sulfated chitosan Original Research Article
862
Anticoagulant activity of enzymatically synthesized amylose derivatives containing carboxy or sulfonate groups
863
Anticoagulant activity of marine green and brown algae collected from Jeju Island in Korea
864
Anticoagulant activity of Triatoma infestans and Panstrongylus megistus saliva (Hemiptera/Triatominae)
865
Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenans
866
Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenans
867
Anticoagulant agents in the management of pulmonary embolism
868
Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
869
Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation: Implications for Bleeding Risk and Prognosis Original Research Article
870
Anticoagulant and antithrombotic activity of a sulfate obtained from a glucan component of the lichen Parmotrema mantiqueirense Hale
871
Anticoagulant effectiveness of glycosaminoglycan extracted from the scale of Binni, Mesopotamichthys sharpeyi (Cyprinidae)
872
Anticoagulant Effects of Glycosaminoglycan Extracted from Fish Scales
873
Anticoagulant effects of sulphonated polyisoprenes
874
Anticoagulant induced leukoagglutination
875
Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum
876
Anticoagulant mechanism of sulfonated polyisoprenes
877
Anticoagulant monitoring with transcranial doppler
878
Anticoagulant potential of regioselective derivatized cellulose
879
Anticoagulant properties of dextranmethylcarboxylate benzylamide sulfate (DMCBSu); a new generation of bioactive functionalized dextran Original Research Article
880
Anticoagulant Proteins in Childhood Venous and Arterial Thrombosis: A Review
881
Anticoagulant Proteins in Childhood Venous and Arterial Thrombosis: A Review: Volume 26, Number 5 (2000), pages 540–560
882
Anti-coagulant rodenticide binding properties of human serum albumin: a biochromatographic approach
883
Anticoagulant Rodenticide Intoxication in Animals – A Review
884
Anticoagulant rodenticides in stoats (Mustela erminea) and weasels (Mustela nivalis) in England
885
Anticoagulant sulfated polysaccharides: Part I. Synthesis and structure–activity relationships of new pullulan sulfates
886
Anticoagulant therapy for ischemic stroke: A review of literature
887
Anticoagulant Therapy in Pregnancy
888
Anticoagulant-induced intramural intestinal hematoma
889
Anticoagulant-Induced Skin Necrosis in a Patient With Hereditary Deficiency of Protein S
890
Anticoagulants
891
Anticoagulants and antiplatelet agents in acute ischaemic stroke
892
Anticoagulants in acute coronary syndromes
893
Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy
894
Anticoagulants in the treatment of deep vein thrombosis
895
Anticoagulation after cardioversion in atrial fibrillation: How long should we warfarinise for
896
Anticoagulation and Pediatric Extracorporeal Membrane Oxygenation: Impact of Activated Clotting Time and Heparin Dose on Survival
897
Anticoagulation clinics are needed in developing countries
898
Anti-Coagulation during Pregnancy in Women with Mechanical Heart Valves: A Prospective Study
899
Anticoagulation for Atrial Fibrillation Ablation: What Is the Optimal Strategy?
900
Anticoagulation for Nonvalvular Atrial Fibrillation: Effects of Type of Practice on Physicians’ Self-Reported Behavior
901
Anticoagulation for non-valvular atrial fibrillation: new anticoagulant agents
902
Anticoagulation for secondary stroke prevention: another nail in the coffin?
903
Anticoagulation for the Pregnant Patient with a Mechanical Heart Valve, No Perfect Therapy: Review of Guidelines for Anticoagulation in the Pregnant Patient
904
Anticoagulation for Thromboembolism and Anticardiolipin-Antibody Positivity in Lemierre Disease
905
Anticoagulation in acute cardiac care in patients with chronic kidney disease
906
Anticoagulation in atrial fibrillation
907
Anticoagulation in atrial fibrillation
908
Anticoagulation in Children With Mechanical Valve Prostheses
909
Anticoagulation in Dilated Cardiomyopathy
910
Anticoagulation in high-risk patients: when is this approach not worth the risk?
911
Anticoagulation in Lower Risk Atrial Fibrillation: A two Edged Sword
912
Anticoagulation in Lower Risk Atrial Fibrillation: A two Edged Sword
913
Anticoagulation in Non-Valvular Atrial Fibrillation: Underused or Wrongly Used?
914
Anticoagulation in Patients With Atrial Fibrillation and Congestive Heart Failure
915
Anticoagulation in pregnant women with prosthetic heart valves: double jeopardy
916
Anticoagulation management in clinical practice: Preventing stroke in patients with atrial fibrillation
917
Anticoagulation management of patients with prosthetic valves
918
Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter
919
Anticoagulation Strategies for the Orthopaedic Surgeon: Reversal and Timelines
920
Anti-coagulation therapy following coronary endarterectomy in patient with coronary artery bypass graft
921
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines
922
Anticoagulation Therapy in High Risk Patients with Atrial Fibrillation: Retrospective Study in a Regional Hospital
923
Anticoagulation therapy: bleeding and thromboembolic complications
924
Anticoagulation therapy: bleeding and thromboembolic complications
925
Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery
926
Anticoagulative Effect of Two Species of Brown Algae: Sargassum Angustifolium and Cystoseira Indica
927
Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II
928
Anti-Coal Lobby Wins Another Round, Now Against Xcel in NY
929
Anti-coincidence rejection of SiPM dark pulses for improved detection of low energy radiation
930
Anti-coincidence rejection of SiPM dark pulses for improved detection of low energy radiation
931
Anti-coking property of the SiO2/S coating during light naphtha steam cracking in a pilot plant setup
932
Anti-coking property of the SiO2/S coating during light naphtha steam cracking in a pilot plant setup
933
Anti-collagen antibodies and immune complexes in equine joint diseases
934
Anti-collagen antibodies and immune complexes in equine joint diseases
935
Anti-collusion fingerprinting for multimedia
936
Anti-Collusion Forensics of Multimedia Fingerprinting Using Orthogonal Modulation
937
Anti-Colon Cancer, Anti-HMG-CoA Reductase, Anti-Urease Activities, and Molecular Docking Studies of Some Natural Compounds
938
Anticoloring and separation of graphs
939
Anti-competition Issues between Taiwanʹs cable TV system operators and channel providers—new rules of engagement?
940
Anti-competitive conduct, in-house R&D, and growth
941
Anti-competitive Practices under Section 52 of the Malaysian Aviation Commission Act 2015
942
Anti-complementary activity of flavonoids from Gnaphalium affine D. Don
943
Anti-Compliment Factor H Antibody Associated Hemolytic Uremic Syndrome in Children with Abbreviated Plasma Exchanges: A 12-Month Follow-up Study
944
Anticompton spectrometer element studies
945
Anti-consumption and brand avoidance
946
Anti-consumption discourses and consumer-resistant identities
947
Anti-consumption: An overview and research agenda
948
Anti-contamination device for cryogenic soft X-ray diffraction microscopy
949
Anti-contamination device for cryogenic soft X-ray diffraction microscopy
950
Anticontrol and synchronization of chaos for an autonomous rotational machine system with a hexagonal centrifugal governor
951
Anticontrol of chaos for dynamic systems in p-normal form: A homogeneity-based approach
952
Anti-control of chaos in rigid body motion
953
Anti-control of chaos of a permanent magnet DC motor system for vibratory compactors
954
Anti-control of chaos of single time scale brushless dc motors and chaos synchronization of different order systems
955
Anti-control of chaos of two-degrees-of-freedom loudspeaker system and chaos synchronization of different order systems
956
Anti-control of continuous-time dynamical systems
957
Anti-controlling quasi-periodic impact motion of an inertial impact shaker system
958
Anticonvulsant action of anandamide in an in vitro model of epilepsy
959
Anticonvulsant Activities of 7-phenyl-5H-thiazolo[5,4-e][1,2,3,4] tetrazolo[5,1-c]pyrrolo[1,2-a][1,4]diazepine and 7-phenyl-5H-thiazolo[5,4-e][1,3,4]triazolo[5,1-c] pyrrolo[1,2-a][1,4]diazepines
960
Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: A clinical pilot study
961
Anticonvulsant activity of Astragalus squarrosus Bunge
962
Anticonvulsant activity of atorvastatin against seizure induced by pentylenetetrazole and maximal electroshock in mice
963
Anticonvulsant Activity of Carissa carandas Linn. Root Extract in Experimental Mice
964
Anticonvulsant activity of dapsone analogs: Electrophysiologic evaluation
965
Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors
966
Anticonvulsant activity of furanocoumarins and the essential oil obtained from the fruits of Heracleum crenatifolium
967
Anticonvulsant Activity of Hydroalcoholic Extract and Aqueous Fraction of Ebenus stellata in Mice
968
Anticonvulsant activity of novel 1-(morpholinomethyl)-3-substituted isatin derivatives
969
Anticonvulsant activity of some xanthone derivatives Original Research Article
970
Anticonvulsant Activity of Teucrium polium Against Seizure Induced by PTZ and MES in Mice
971
Anticonvulsant Activity of the Aqueous Leaf Extract Of Croton Zambesicus (Euphorbiaceae) In Mice and Rats
972
Anticonvulsant Activity of Viola tricolor against Seizures Induced by Pentylenetetrazol and Maximal Electroshock in Mice
973
Anticonvulsant and ameliorative effects of pioglitazone on cognitive deficits, inflammation and apoptosis in the hippocampus of rat pups exposed to febrile seizure
974
Anticonvulsant and antiepileptogenic effects of azolylchromanones on lithium–pilocarpine induced seizures and pentylenetetrazole-kindling model of epilepsy
975
Anticonvulsant and Antimicrobial Activity of Cu (II), Zn (II) and Co (II) Complex of Isatin 3-Glycine
976
Anticonvulsant and Antioxidant Effects of Pitavastatin Against PentylenetetrazolInduced Kindling in Mice
977
Anticonvulsant and Antioxidant Effects of Pitavastatin Against Pentylenetetrazol-Induced Kindling in Mice
978
Anticonvulsant and neuroprotective effects of Rosa damascena hydro-alcoholic extract on rat hippocampus
979
Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogue
980
Anticonvulsant and Toxicity Evaluation of Newly Synthesized 1-[2-(3,4-disubstituted phenyl) -3-chloro-4-oxoazetidin-1-yl]-3-(6-substituted -1,3-benzothiazol-2-yl)ureas
981
Anticonvulsant and toxicity evaluation of some 7-alkoxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline-1(2H)-ones Original Research Article
982
Anticonvulsant effect of acute curcumin nanoparticle on pentylenetetrazole-induced seizuresin mice: non-involvement of JNK restoration
983
Anticonvulsant Effect of Alcea aucheri on Pentylenetetrazole and Maximal Electroshock Seizures in Mice
984
Anticonvulsant effect of celecoxib on pentylenetetrazoleinduced convulsion: modulation by NO pathway
985
Anticonvulsant Effect of Cicer arietinum Seed in Animal Models of Epilepsy: Introduction of an Active Molecule with Novel Chemical Structure
986
Anticonvulsant Effect of Ethyl Acetate and n-hexane Fractions of Celosia leptostachya Leaf Extracts in Mice
987
Anticonvulsant Effect of Ferula Gummosa Root Extract against Experimental Seizures
988
Anticonvulsant Effect of Guaifenesin against Pentylenetetrazol-Induced Seizure in Mice
989
Anticonvulsant effect of Satureja hortensis L. aerial parts extracts in mice
990
ANTICONVULSANT EFFECT OF SOUR ORANGE FLOWERS EXTRACT IN EXPERIMENTAL PENTYLENETETRAZOL-INDUCED SEIZURES IN RAT
991
Anticonvulsant Effect of the Aqueous Extract and Essential Oil of Carum Carvi L. Seeds in a Pentylenetetrazol Model of Seizure in Mice
992
ANTICONVULSANT EFFECTS OF AQUEOUS AND ETHANOLIC EXTRACTS OF CROCUS SATIVUS L. STIGMAS IN MICE
993
Anticonvulsant Effects of Intracerebroventricular Adenocard in Theophylline-Induced Seizures, ,
994
Anticonvulsant Effects of Lippia citriodora (Verbenaceae) Leaves Ethanolic Extract in Mice: Role of GABAergic System
995
Anticonvulsant Effects of New 1, 4-DihydropyridineDerivatives Containing Imidazolyl Moiety Against Seizures Induced by Pentylenetetrazole and Maximal Electroshock in Mice
996
Anticonvulsant effects of new morphinan derivatives
997
Anticonvulsant effects of squill oxymel (a traditional formulation) in mice
998
Anticonvulsant evaluation and mechanism of action of benzylamino enaminones Original Research Article
999
Anticonvulsant Hypersensitivity Syndrome: Treatment With Corticosteroids and Intravenous Immunoglobulin
1000
Anticonvulsant Profile of Ondansetron in Rats
بازگشت